Rep. Keller Announces Passage Of "Epinephrine Accessibility Act"
House Bill 101 addresses concerns of rising cost of epinephrine
 
 

COLUMBUS—State Representative Candice Keller (R-Middletown) today announced passage of House Bill 101, the Epinephrine Accessibility Act, which seeks to make epinephrine auto-injectors more affordable and accessible for Ohioans who rely on the medication to treat life-threatening allergic reactions.


House Bill 101, sponsored by State Representative Derek Merrin (R-Monclova Township), allows pharmacists to substitute a pharmaceutically equivalent epinephrine auto-injector for another auto-injector. Currently, these auto-injectors are unable to be substituted with a generic prescription or other brand name auto-injector under state law in most instances.


“This vital medication legislation was much needed,” Keller said. “I’m happy to see a unanimous vote on a drug made more accessible to our communities.”


National media has recently shed light on the skyrocketing price of the life-saving device commonly known as EpiPen, which has increased nearly 500 percent in recent years, bringing the retail price to its current rate of more than $600.


For the many Ohioans at risk of anaphylactic shock, epinephrine delivered by an auto-injector is a medical necessity that oftentimes serves as a life-saving solution. Under this bill, consumers will have increased ability to secure the best epinephrine auto-injector at a competitive price, rather than being forced to purchase the most expensive product on the market. In some instances, House Bill 101 could help patients save as much as $500.



The Epinephrine Accessibility Act was passed with bipartisan support and now heads to the Ohio Senate for further consideration.


 

 
 
 
  
Featured Posts